Overall, rising unit sales\u2014predominantly due to an aging population\u2014and the uptake of premium-priced products will spur revenue growth in the European vascular access device market.<\/p>\n
This\u00a0Medtech 360 Report\u00a0provides comprehensive data and analysis on the current state of the market for vascular access\u00a0devices in Europe across a 10-year period.<\/p>\n
\u00a0<\/p>\n
Companies have developed innovative products designed to reduce the likeliness of catheter-related\u00a0BSIs and clot formation<\/strong><\/p>\n How will the various vascular access device markets be affected by the introduction of novel technologies?<\/p>\n What innovative products have companies introduced in Europe to cater to this unmet need? How will these products be adopted over the forecast period?<\/p>\n Which regions will see stronger growth in adoption of these innovative devices and which regions will experience restricted growth?<\/p>\n How will clinical trials examining the incidence of\u00a0DVT\u00a0among vascular access patients impact the market?<\/p>\n The\u00a0<\/strong>PICC\u00a0segment will see rapid market growth in Europe.<\/strong><\/p>\n How does the adoption of\u00a0PICCs vary between countries and what factors are responsible for these differences?<\/p>\n How will the rapid adoption of\u00a0PICCs affect other vascular access device segments?<\/p>\n The dialysis catheter segment has witnessed several acquisitions in Europe.<\/strong><\/p>\n How have these acquisitions affected the competitive landscape in the dialysis catheter market?<\/p>\n What characteristics made these companies attractive acquisition targets?<\/p>\n","protected":false},"template":"","class_list":["post-386827","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-vascular-access-devices","medtech-geography-europe","medtech-date-857"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386827","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386827\/revisions"}],"predecessor-version":[{"id":388323,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386827\/revisions\/388323"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=386827"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}